Clinical Trials Sponsored by The CORE Institute

Total 5922 results

The Netherlands Cancer Institute

Terminated

Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F)

Cervical Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy (ADMIRE)

Head and Neck Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

PET Response During Chemoradiation of Lung Cancer

NSCLC

Netherlands
The Netherlands Cancer Institute

Unknown

The Effectiveness of Patient Navigation in Cancer Care

Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer (DOP)

Prostatic Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

Neoplasms

Netherlands
Sepsicure
The Rogosin Institute

Completed

Lipid Infusion in Dialysis Patients With Endotoxemia (LIPIDOSE)

Fatigue | End Stage Renal Disease (ESRD)

United States
The Netherlands Cancer Institute

Recruiting

Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer (PAPBI-3)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Peri-operative Slow-paced Breathing to Reduce Anxiety in Breast Cancer Surgery Patients (SlowPACE)

Anxiety

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

LB-100 (PP2A Inhibitor) and Azenosertib (WEE1 Inhibitor) in Metastatic Colorectal Cancer Patients

Metastatic Colorectal Cancer
The Netherlands Cancer Institute

Not yet recruiting

LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients (CoLBAt)

Metastatic Microsatellite-stable Colorectal Cancer
The Netherlands Cancer Institute

Not yet recruiting

Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker

Drug Adherence Marker
The Netherlands Cancer Institute

Recruiting

Vessel-based Ultrasound Registration

Abdominal Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial (ESP)

Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction

Netherlands
The Netherlands Cancer Institute

Recruiting

Tracer-Guided Surgery for Recurrent Prostate Cancer (Trace-II)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer. (SPLIT)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery (MATISSE)

Cutaneous Squamous Cell Carcinoma

Netherlands
The Netherlands Cancer Institute

Recruiting

Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) (VULCANize)

Locally Advanced, Squamous Cell Carcinoma of the Vulva

Netherlands
The Netherlands Cancer Institute

Recruiting

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy (CRAVAT)

Metastatic Squamous Cell Carcinoma of the Vulva

Netherlands
The Netherlands Cancer Institute

Recruiting

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)

Ovarian Cancer

Netherlands, United States, France, Denmark, Italy, Sweden, Ireland
The Netherlands Cancer Institute

Not yet recruiting

Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour (SENATOR)

Testicular Germ Cell Tumor
The Netherlands Cancer Institute

Completed

ctDNA as a Biomarker for Treatment Response in HNSCC (PECAN)

Carcinoma, Squamous Cell of Head and Neck

Netherlands
The Netherlands Cancer Institute

Completed

ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (IMCISION)

Head and Neck Neoplasms | Immunotherapy

Netherlands
The Netherlands Cancer Institute

Completed

CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours

Prostate Cancer | Solid Tumor, Adult

Netherlands
The Netherlands Cancer Institute

Completed

Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy (CATCHER)

Colorectal Neoplasms | Testicular Cancer

Netherlands
The Netherlands Cancer Institute

Completed

INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue (INFLUENCE)

Head and Neck Cancer | Penile Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer (Oligo)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (OSTRICh)

Metastasis | Prostate Cancer Metastatic

Netherlands
The Netherlands Cancer Institute

Unknown

Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer (B-DOCT)

Metastatic Gastric Cancer | Adenocarcinoma of the Gastro-oesophageal Junction

Netherlands
The Netherlands Cancer Institute

Unknown

Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study (TRACE)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer (COOPERATION)

Head and Neck Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously (VOLUMES)

Lung Cancer | Metastatic Lung Cancer

Netherlands, United States, Canada, Germany
The Netherlands Cancer Institute

Completed

Organ Motion and Early Tumor Response Measurement

Esophageal Cancer | Chemoradiation

Netherlands
The Netherlands Cancer Institute

Completed

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer (REVIVAL)

Breast Cancer | Ovarian Cancer | Advanced Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir

Cancer

Netherlands
The Aurum Institute NPC

Unknown

TB Host Directed Therapy (TBHDT)

Tuberculosis

South Africa
The Netherlands Cancer Institute

Unknown

Study With T-cel Receptor Gene Therapy in Metastatic Melanoma (TCR)

Stage IV Skin Melanoma | Eye; Melanoma

Netherlands
The Netherlands Cancer Institute

Completed

Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Clinical Impact of Dedicated MR Staging of Ovarian Cancer (MRStagingOC)

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Completed

4D FDG PET in Esophageal Cancer

Esophageal Cancer

Netherlands
The Netherlands Cancer Institute

Completed

The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer (M16SDM)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity

Drug Safety Biomarkers

Netherlands
The Netherlands Cancer Institute

Completed

Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots

Cocaine Addiction

Netherlands
The Netherlands Cancer Institute

Unknown

Prospective Pilot Study ANDPrecise (ANDPrecise)

Breast Cancer

Netherlands
The George Institute
Servier

Completed

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study (ADVANCE-ON)

Diabetes Mellitus, Type 2

Australia, Canada, China, Czech Republic, Estonia, France, Germany, Hungary, India, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Philippines, Poland, Russian Federation, Slovakia, United Kingdom
The Cooper Institute
Cargill

Completed

Phytosterol Supplementation and Cardiovascular Risk

Hypercholesteremia

United States
The Netherlands Cancer Institute

Unknown

Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases

Meningeal Carcinomatosis

Netherlands
The George Institute
Heart Research Institute

Recruiting

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke (STARS)

Acute Ischemic Stroke

Australia

3

Subscribe